Перейти к содержимому

IPB Style© Fisana

Информация о файле

  • Издательство: CINP
  • Год: 2006
  • Кол-во страниц: 298
  • Загружен: 04 Jan 2010 23:50
  • Размер файла: Неизвестно
  • Просмотров: 1443
  • Нумерация страниц в тексте: нет
  • Соответствие оригиналу: нет
  • Статус вычитки: текст вычитан
  • Язык: Английский

Содержание (оглавление)

1 Foreword
2 Editorial introduction
3 Introduction
4 Health Economics - the Cost of illness
4.1 Background
4.2 The broad costs of depression
4.3 Methodology-Economic evaluation
4.4 Economic evidence for pharmacological treatment options
4.5 Evidence on the cost-effectiveness of antidepressants and care management
4.6 Economic evidence for pharmacological treatment options
4.7 Implications – economic evidence for pharmacological treatment options
4.8 Economic evidence for psychological treatment options
5 Diagnosis and Epidemiology
5.1 Diagnosis of depressive disorders
5.2 Specific features of manifestations of depressive syndromes
5.3 Epidemiology of depressive disorders
6 Methodology
6.1 Consensus process
6.2 Data Source
6.3 Limitation
7 Standard of care
7.1 Diagnosis
7.2 Access to Mental Health Services
7.3 Enhanced care
8 Goals of treatment - response, remission, recovery
8.1 Acute treatment
8.2 Continuation treatment
8.3 Maintenance treatment
8.4 Management of side effects
9 Specific age and gender related conditions
9.1 Gender related differences
9.2 Age related differences
10 Mechanisms of action of antidepressants
10.1 The development of antidepressants based on the monoamine hypothesis of depression..
10.2 New developments leading to a new understanding of the mechanism of action of antidepressants
10.3 The role of pharmacogenetics in the understanding of how antidepressants work
11 Pharmacological acute phase treatment options
11.1 Introduction and general information about antidepressants
11.2 Summary of side effects
11.3 Selective serotonin reuptake inhibitors (SSRI)
11.4 Selective serotonin and noradrenaline reuptake inhibitors (SNRI)
11.5 Selective noradrenaline reuptake inhibitors (NARI)
11.6 Monoaminooxidase inhibitors (MAOI, MAOBI, RIMA)
11.7 a2-receptor blocking tetracyclic antidepressants
11.8 Serotonin modulating antidepressants (SMA)
11.9 Dopamine and noradrenaline reuptake inhibitors (DNRI)
11.10 Tri- and tetracyclic antidepressants (TCA)
11.11 Combination treatment
11.12 Herbal antidepressants
11.13 Q-3 polyunsaturated fatty acids
11.14 Augmentation strategies
11.15 New developments and novel pharmacological treatment approaches
12 Pharmacological maintenance therapy
12.1 Continuation treatment
12.2 Prophylactic treatment
13 Suicidality and antidepressants
14 Antidepressant drugs in the treatment of anxiety disorders
14.1 Generalized Anxiety Disorder
14.2 Panic disorder
14.3 Social phobia
14.4 Post-traumatic stress disorder
14.5 Obsessive-compulsive disorder
15 Other treatments
15.1 Psychotherapy
15.2 Electroconvulsive Therapy (ECT)
15.3 Recently developed and other non-pharmacological treatments
16 Conclusions and Implications
17 References
18 Annexes
18.1 Annex 1 - Additional information on the types of economic evaluation
18.2 Annex 2 - Additional information on Electroconvulsive Therapy
18.3 Annex 3 - Additional information on transcranial magnetic stimulation
18.4 Annex 4 - Additional information on vagus nerve stimulation (VNS)
18.5 Annex 5 - Additional information on Acupuncture
18.6 Annex 6 - Additional information on Psychotherapy

  Загрузить Baghai T., Grunze H., Sartorius N. The use and usefulness of antidepressants

* * * * * 1 Голосов

The first six chapters are dedicated to the epidemiology and diagnosis of depression including socio-economic aspects, overall principles of care and treatment goals. In Chapter 6 it also details the methodology how this review has been developed. The main body of the text starting from Chapter 10 is then dedicated to the different aspects of the use of antidepressants: their mechanism of action, the effectiveness and side effect profile of each antidepressant based on the available literature from clinical studies and meta-analysis, the role of combination and augmentation strategies including other pharmacological options, and principles of continuation and prophylactic treatment. The reader will find comprehensive information on these topics for all major antidepressants, divided in chapters according to their main mechanism of action.

Психологический юмор, анекдоты